Susanne Grafe
Applied Pharma Research (Switzerland)(CH)
Publications by Year
Research Areas
Botulinum Toxin and Related Neurological Disorders, Neurological disorders and treatments, Hereditary Neurological Disorders, Cancer Treatment and Pharmacology, Parkinson's Disease and Spinal Disorders
Most-Cited Works
- → A new botulinum toxin type A free of complexing proteins for treatment of cervical dystonia(2005)270 cited
- → Efficacy and safety of a new Botulinum Toxin Type A free of complexing proteins in the treatment of blepharospasm(2005)246 cited
- → Relationship between various clinical outcome assessments in patients with blepharospasm(2008)161 cited
- → Efficacy and safety of incobotulinumtoxinA (NT 201, XEOMIN®, botulinum neurotoxin type A, without accessory proteins) in patients with cervical dystonia(2011)143 cited
- → Botulinum Neurotoxin Type A Free of Complexing Proteins (XEOMIN??) in Focal Dystonia(2007)138 cited
- → Efficacy and Safety of Botulinum Neurotoxin NT 201 in Poststroke Upper Limb Spasticity(2009)118 cited
- → Efficacy and safety of incobotulinumtoxinA (NT 201, Xeomin) in the treatment of blepharospasm—A randomized trial(2011)92 cited
- → Efficacy and safety of treatment with Incobotulinum toxin A (botulinum neurotoxin type A free from complexing proteins; NT 201) in post-stroke upper limb spasticity(2011)87 cited
- → Neurophysiological Double-Blind Trial of a Botulinum Neurotoxin Type A Free of Complexing Proteins(2007)73 cited
- → A randomized, double-blind study of repeated incobotulinumtoxinA (Xeomin®) in cervical dystonia(2013)71 cited